[HTML][HTML] Cervical cancer therapies: Current challenges and future perspectives

CA Burmeister, SF Khan, G Schäfer, N Mbatani… - Tumour Virus …, 2022 - Elsevier
Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Cervical cancer: prevention, diagnosis, and therapeutics

MF Janicek, HE Averette - CA: a cancer journal for clinicians, 2001 - Wiley Online Library
Cervical cancer is a leading cause of cancer deaths in women worldwide. Because of its
association with human papilloma virus infection, as well as the ability to screen for …

New strategies in advanced cervical cancer: from angiogenesis blockade to immunotherapy

KS Tewari, BJ Monk - Clinical Cancer Research, 2014 - AACR
Cervical cancer remains unique among solid tumor malignancies. Persistent infection with
oncogenic subtypes of the human papillomavirus (HPV) results in carcinogenesis …

Novel chemotherapy approaches for cervical cancer

S Movva, L Rodriguez, H Arias‐Pulido… - … Journal of the …, 2009 - Wiley Online Library
Cancer of the cervix is the second most common malignancy among women worldwide. The
last 20 years have lead to numerous advances in the medical management of locally …

Current and potential treatments for cervical cancer

G PC Yee, P de Souza… - Current cancer drug …, 2013 - ingentaconnect.com
Cervical cancer is the third most common carcinoma in women worldwide. Despite
increasing efforts to improve therapy in this disease, a significant proportion of women still …

Targeted treatments for cervical cancer: a review

O Peralta-Zaragoza, VH Bermúdez-Morales… - OncoTargets and …, 2012 - Taylor & Francis
Cervical cancer is the second most common cause of cancer death in women worldwide
and the development of new diagnosis, prognostic, and treatment strategies merits special …

Immunotherapy and targeted therapy for cervical cancer: an update

G Menderes, J Black, CL Schwab… - Expert review of …, 2016 - Taylor & Francis
The prognosis of patients with metastatic cervical cancer is poor with a median survival of 8–
13 months. Despite the potency of chemotherapeutic drugs, this treatment is rarely curative …

Updates on systemic therapy for cervical cancer

P Gopu, F Antony, S Cyriac, K Karakasis… - Indian Journal of …, 2021 - journals.lww.com
Cervical cancer is one of the most common cancers in the world both in terms of incidence
and mortality, more so important in low-and middle-income countries. Surgery and …

Updates in cervical cancer treatment

EK Hill - Clinical Obstetrics and Gynecology, 2020 - journals.lww.com
Although rates of cervical cancer in the United States have been declining due to
vaccination and screening efforts, it remains the fourth most common cancer in women …

Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis, D Chrysikos, M Filipits… - Gynecologic …, 2012 - Elsevier
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …